Lütfiye Ömür DEMİREZER, Perihan GÜRBÜZ, Emine Pelin Kelicen UĞUR, Mine BODUR, Nadire ÖZENVER, Ayşe UZ, Zühal GÜVENALP

Molecular docking and ex vivo and in vitro anticholinesterase activity studies ofSalvia sp. and highlighted rosmarinic acid

Background/aim: To evaluate acetylcholinesterase (AChE) inhibitory activity and antioxidant capacity of the major molecule from Salvia sp., rosmarinic acid, as a drug candidate molecule for treatment of Alzheimer disease (AD). Materials and methods: The AChE inhibitory activity of different extracts from Salvia trichoclada, Salvia verticillata, and Salvia fruticosa was determined by the Ellman and isolated guinea pig ileum methods, and the antioxidant capacity was determined with DPPH. The AChE inhibitory activity of the major molecule rosmarinic acid was determined by in silico docking and isolated guinea pig ileum methods. Results: The methanol extract of Salvia trichoclada showed the highest inhibition on AChE. The same extract and rosmarinic acid showed significant contraction responses on isolated guinea pig ileum. All the extracts and rosmarinic acid showed high radical scavenging capacities. Docking results of rosmarinic acid showed high affinity to the selected target, AChE. Conclusion: In this study in vitro and ex vivo studies and in silico docking research of rosmarinic acid were used simultaneously for the first time. Rosmarinic acid showed promising results in all the methods tested.

Anahtar Kelimeler:

Salvia, rosmarinic acid, acetylcholinesterase, isolated guinea pig ileum, computational screening

Molecular docking and ex vivo and in vitro anticholinesterase activity studies ofSalvia sp. and highlighted rosmarinic acid

Keywords:

Salvia, rosmarinic acid, acetylcholinesterase, isolated guinea pig ileum, computational screening,

PDF

___

Houghton P, Howes MJ. Natural products and derivatives affecting neurotransmission relevant to Alzheimer’s and Parkinson’s disease. Neurosignals 2005; 14: 6–22.
Nordberg A. PET imaging of amyloid in Alzheimer’s disease. Lancet Neurol 2004; 3: 519–527.
Rusted JM, Newhouse PA, Levin ED. Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer’s disease and Parkinson’s disease. Behav Brain Res 2000; 113: 121–129.
Mukherjee PK, Kumar V, Mal M, Houghton PJ. Acetylcholinesterase inhibitors from plants. Phytomedicine 2007; 14: 289–300.
Markesbery WR. Oxidative stress hypothesis in Alzheimer’s disease. Free Radic Biol Med 1997; 23: 134–147. 6. Puig B, Gómez‐Isla T, Ribe E, Cuadrado M, Torrejón‐Escribano B, Dalfo E, Ferrer I. Expression of stress‐activated kinases c‐ Jun N‐terminal kinase (SAPK/JNK‐P) and p38 kinase (p38‐P), and tau hyperphosphorylation in neurites surrounding βA plaques in APP Tg2576 mice. Neuropath Appl Neuro 2004; 30: 491–502.
Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: a double blind, randomized and placebo-controlled trial. J Clin Pharm Ther 2003; 28: 53–59. 8. Perry NS, Bidet N, Perry EK. European herbs with cholinergic activities: potential in dementia therapy. Int J Geriatric Psychiatry 1996; 11: 1063–1069.
Perry NS, Bollen C, Perry EK, Ballard C. Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav 2003; 75: 651–659.
Perry NS, Houghton PJ, Theobald A, Jenner P, Perry EK. In- vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes. J Pharm Pharmacol 2000; 52: 895–902.
Iuvone T, De Filippis D, Esposito G, D’Amico A, Izzo AA. The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-β peptide-induced neurotoxicity. J Pharmacol Exp Ther 2006; 317: 1143–1149.
Kuang P, Xiang J. Effect of radix salviae miltiorrhizae on EAA and IAA during cerebral ischemia in gerbils: a microdialysis study. J Tradit Chin Med 1994; 14: 45–50.
Hedge IC. Salvia. In: Davis PH, editor. Flora of Turkey and the East Aegean Islands. Edinburgh, UK: Edinburgh University Press; 1982. pp. 400–461.
Luis JG, González AG, Andrés LS, Mederos S. Diterpenes from in vitro-grown Salvia canariensis. Phytochemistry 1992; 31: 3272–3273.
Ulubelen A, Topcu G. Abietane diterpenoids from Salvia pomifera. Phytochemistry 1992; 31: 3949–3951.
Banthorpe DV, Bilyard HJ, Brown GD. Enol esters of caffeic acid in several genera of the Labiatae. Phytochemistry 1989; 28: 2109–2113.
Çadırcı E, Süleyman H, Gürbüz P, Kuruüzüm Uz A, Güvenalp Z, Demirezer LÖ. Anti-inflammatory effects of different extracts from three Salvia species. Turk J Biol 2012; 36: 59–64.
Demirezer OL, Gürbüz P, Kuruüzüm-Uz A, Güvenalp Z, Kazaz C, Dönmez AA. Chemical constituents of two sages with free radical scavenging activity. Nat Prod Commun 2012; 7: 187– 190.
Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88– 95.
Burits M, Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytother Res 2000; 14: 323–328.
Cuendet M, Hostettmann K, Potterat O, Dyatmiko W. Iridoid glucosides with free radical scavenging properties from Fagraea blumei. Helv Chim Acta 1997; 80: 1144–1152.
Archana P, Sathishkumar N, Bharathi N. In silico docking analysis of curcumin–an inhibitor for obesity. International Journal of Pharma and Bio Sciences 2010; 1: 224–235.
Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C. Patterns of somatic mutation in human cancer genomes. Nature 2007; 446: 153–158.
Litchfield D. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J 2003; 369: 1–15.
Orhan IE, Senol FS, Ercetin T, Kahraman A, Celep F, Akaydin G, Sener B, Dogan M. Assessment of anticholinesterase and antioxidant properties of selected sage (Salvia) species with their total phenol and flavonoid contents. Industrial Crops and Products 2013; 41: 21–30.
Şenol FS, Orhan I, Celep F, Kahraman A, Doğan M, Yilmaz G, Şener B. Survey of 55 Turkish Salvia taxa for their acetylcholinesterase inhibitory and antioxidant activities. Food Chem 2010; 120: 34–43.
Orhan I, Aslan S, Kartal M, Şener B, Can Başer KH. Inhibitory effect of Turkish Rosmarinus officinalis L. on acetylcholinesterase and butyrylcholinesterase enzymes. Food Chem 2008; 108: 663–668.
Kuruuzum-Uz A, Suleyman H, Cadirci E, Guvenalp Z, Demirezer LO. Investigation on anti-inflammatory and antiulcer activities of Anchusa azurea extracts and their major constituent rosmarinic acid. Z Naturforsch C 2012; 67: 360– 366.
Tandogan B, Kuruüzüm-Uz A, Sengezer C, Güvenalp Z, Demirezer LÖ, Nuray Ulusu N. In vitro effects of rosmarinic acid on glutathione reductase and glucose 6-phosphate dehydrogenase. Pharm Biol 2011; 49: 587–594.